|
|
 |
 |
 |
Accredo Health Group, Inc., provides its services through three divisions. The use of one corporate name for all three makes it easier for the managed care community to recognize our name and to access all our services. Our streamlined organization will save you time and effort!
Although we’re one company, each of our divisions continues to operate with its own clinical service model and focus.
|
|
ACCREDO THERAPEUTICS
Our therapeutics division is the country’s most extensive pharmacy network dedicated to the treatment of:
- Autoimmune disorders and primary immune deficiencies as treated with IG therapy
- Pulmonary arterial hypertension (PAH)
- Alpha-1 antitrypsin deficiency
- Lysosomal storage disorders
- End stage renal disease (ESRD) dialysis patients who need nutritional support as treated with intraperitoneal (IPN) and intradialytic parenteral nutrition (IDPN).
Our pharmacists and nurses are specially trained in these infusion therapies, and they work with each patient to provide counseling specific to the therapy. IG patients need skilled support, and our network of nurses answers that need, plus the instructional needs among our patients generally. Through all this, ATX has built trusting relationships with top healthcare systems, academic medical centers, private physicians, and managed care organizations. |
|
|
|
ACCREDO HEMOPHILIA
“Rare,” “chronic,” and “costly” are signature descriptions of hemophilia, a genetic condition characterized by the deficiency of an essential blood-clotting protein. Occurring almost exclusively in males, this condition is one of the most costly to treat, but it’s also quite manageable. HHS provides therapies for other coagulation defects, too. We’ve developed our exclusive Hemophilia Therapy Management Program to help reduce healthcare costs while improving quality of life for anyone with a bleeding condition.
HHS has a comprehensive catalogue of products, including all name-brand factor concentrates, in a complete range of assays. As the nation’s largest purchaser of clotting factor, HHS has access to larger allocations to ensure a consistent supply. Along with clotting factor, we also offer a full line of infusion devices and supplies. |
|
|
|
ACCREDO NOVA FACTOR
Traditional pharmacy distribution channels often don’t meet the requirements posed by specialty drugs. Accredo Nova Factor, our biopharmaceutical division, focuses on a select group of oral and injectable drugs that require customized treatment programs.
Proactive education and timely follow-up can make all the difference in achieving positive outcomes. At ANF, our dedicated pharmacy teams focus on therapy management. The expertise they build helps them form trusting relationships with patients, and the team becomes a valuable resource for physicians as they work to keep patients in harmony with their treatment. |
| |
 |
|
ACCREDO Clinical Business Solutions
Not a division but an affiliate, CBS delivers a full spectrum of call center and clinical support services to manufacturers throughout the research, development, launch, and market phases of their products. Many of our clients have seen increased patient and prescriber acceptance as a result of our involvement in their product.
Whether your company makes pharmaceuticals, biotechnologicals, or medical devices, CBS can customize a plan to meet your outsourcing needs, and we’ll help you match your program to targeted objectives.
CBS is your complete source for feasibility studies, operational manuals, call center services, clinical liaison programs, research support, benefit investigation, and coordination of in-home nursing services. To find out more about CBS’s clinical support services, please visit www.accredocbs.com
|
| |
|
|
| |
|
|
|
Search Drugs or Therapies
Doctor Referral Form
Patient Authorization Form